glp-1 and multiple sclerosis GLP-1s Full article: Glucagon‑like peptide‑1 receptor
Description
A new study uncovered an association between glucagon-like peptide-1 receptor agonist (GLP-1RAs) use and an increased risk of gastroparesis (GP) among patients with Type 2 diabetes.
Retatrutide could become the biggest drug in history
Overall, the study supports current guideline flexibility, indicating that both GLP-1RAs and SGLT2 inhibitors provide broadly similar cardiovascular protection
Read all you need to know about switching from Mounjaro to Wegovy.
Executive Summary Introduction
Take 2 capsules once a day before a meal
